Private equity’s control of health-care companies requires greater scrutiny to better assess the impact on the industry, several U.S. lawmakers said Thursday.
You may also like
Biden Eyes Russia Retaliation After Meddling, Hacking...
What Ideas Are in Play in the Latest U.S. Gun Debate
India’s Virus Epicenter Has Only Three Days of...
Biden Tax Plan Targets Fossil Fuel Subsidies Worth $35...
Pro-Democracy Hong Kong Activist Nathan Law Given...
Germany May Spread Doses; Poland Deaths Hit Record:...
About the author
